Multiplexing seven miRNA-Based shRNAs to suppress HIV replication

Jang Gi Choi, Preeti Bharaj, Sojan Abraham, Hongming Ma, Guohua Yi, Chunting Ye, Ying Dang, N. Manjunath, Haoquan Wu, Premlata Shankar

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Multiplexed miRNA-based shRNAs (shRNA-miRs) could have wide potential to simultaneously suppress multiple genes. Here, we describe a simple strategy to express a large number of shRNA-miRs using minimal flanking sequences from multiple endogenous miRNAs. We found that a sequence of 30 nucleotides flanking the miRNA duplex was sufficient for efficient processing of shRNA-miRs. We inserted multiple shRNAs in tandem, each containing minimal flanking sequence from a different miRNA. Deep sequencing of transfected cells showed accurate processing of individual shRNA-miRs and that their expression did not decrease with the distance from the promoter. Moreover, each shRNA was as functionally competent as its singly expressed counterpart. We used this system to express one shRNA-miR targeting CCR5 and six shRNA-miRs targeting the HIV-1 genome. The lentiviral construct was pseudotyped with HIV-1 envelope to allow transduction of both resting and activated primary CD4 T cells. Unlike one shRNA-miR, the seven shRNA-miR transduced T cells nearly abrogated HIV-1 infection in vitro. Additionally, when PBMCs from HIV-1 seropositive individuals were transduced and transplanted into NOD/SCID/IL-2R γc -/- mice (Hu-PBL model) efficient suppression of endogenous HIV-1 replication with restoration of CD4 T cell counts was observed. Thus, our multiplexed shRNA appears to provide a promising gene therapeutic approach for HIV-1 infection.

Original languageEnglish (US)
Pages (from-to)310-320
Number of pages11
JournalMolecular Therapy
Volume23
Issue number2
DOIs
StatePublished - Feb 3 2015
Externally publishedYes

Fingerprint

MicroRNAs
Small Interfering RNA
HIV
HIV-1
T-Lymphocytes
HIV Infections
High-Throughput Nucleotide Sequencing
CD4 Lymphocyte Count
Genes
Genome

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Genetics
  • Drug Discovery
  • Pharmacology

Cite this

Choi, J. G., Bharaj, P., Abraham, S., Ma, H., Yi, G., Ye, C., ... Shankar, P. (2015). Multiplexing seven miRNA-Based shRNAs to suppress HIV replication. Molecular Therapy, 23(2), 310-320. https://doi.org/10.1038/mt.2014.205

Multiplexing seven miRNA-Based shRNAs to suppress HIV replication. / Choi, Jang Gi; Bharaj, Preeti; Abraham, Sojan; Ma, Hongming; Yi, Guohua; Ye, Chunting; Dang, Ying; Manjunath, N.; Wu, Haoquan; Shankar, Premlata.

In: Molecular Therapy, Vol. 23, No. 2, 03.02.2015, p. 310-320.

Research output: Contribution to journalArticle

Choi, JG, Bharaj, P, Abraham, S, Ma, H, Yi, G, Ye, C, Dang, Y, Manjunath, N, Wu, H & Shankar, P 2015, 'Multiplexing seven miRNA-Based shRNAs to suppress HIV replication', Molecular Therapy, vol. 23, no. 2, pp. 310-320. https://doi.org/10.1038/mt.2014.205
Choi JG, Bharaj P, Abraham S, Ma H, Yi G, Ye C et al. Multiplexing seven miRNA-Based shRNAs to suppress HIV replication. Molecular Therapy. 2015 Feb 3;23(2):310-320. https://doi.org/10.1038/mt.2014.205
Choi, Jang Gi ; Bharaj, Preeti ; Abraham, Sojan ; Ma, Hongming ; Yi, Guohua ; Ye, Chunting ; Dang, Ying ; Manjunath, N. ; Wu, Haoquan ; Shankar, Premlata. / Multiplexing seven miRNA-Based shRNAs to suppress HIV replication. In: Molecular Therapy. 2015 ; Vol. 23, No. 2. pp. 310-320.
@article{8799e9b3d7364c2181715c05d6ffd457,
title = "Multiplexing seven miRNA-Based shRNAs to suppress HIV replication",
abstract = "Multiplexed miRNA-based shRNAs (shRNA-miRs) could have wide potential to simultaneously suppress multiple genes. Here, we describe a simple strategy to express a large number of shRNA-miRs using minimal flanking sequences from multiple endogenous miRNAs. We found that a sequence of 30 nucleotides flanking the miRNA duplex was sufficient for efficient processing of shRNA-miRs. We inserted multiple shRNAs in tandem, each containing minimal flanking sequence from a different miRNA. Deep sequencing of transfected cells showed accurate processing of individual shRNA-miRs and that their expression did not decrease with the distance from the promoter. Moreover, each shRNA was as functionally competent as its singly expressed counterpart. We used this system to express one shRNA-miR targeting CCR5 and six shRNA-miRs targeting the HIV-1 genome. The lentiviral construct was pseudotyped with HIV-1 envelope to allow transduction of both resting and activated primary CD4 T cells. Unlike one shRNA-miR, the seven shRNA-miR transduced T cells nearly abrogated HIV-1 infection in vitro. Additionally, when PBMCs from HIV-1 seropositive individuals were transduced and transplanted into NOD/SCID/IL-2R γc -/- mice (Hu-PBL model) efficient suppression of endogenous HIV-1 replication with restoration of CD4 T cell counts was observed. Thus, our multiplexed shRNA appears to provide a promising gene therapeutic approach for HIV-1 infection.",
author = "Choi, {Jang Gi} and Preeti Bharaj and Sojan Abraham and Hongming Ma and Guohua Yi and Chunting Ye and Ying Dang and N. Manjunath and Haoquan Wu and Premlata Shankar",
year = "2015",
month = "2",
day = "3",
doi = "10.1038/mt.2014.205",
language = "English (US)",
volume = "23",
pages = "310--320",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Multiplexing seven miRNA-Based shRNAs to suppress HIV replication

AU - Choi, Jang Gi

AU - Bharaj, Preeti

AU - Abraham, Sojan

AU - Ma, Hongming

AU - Yi, Guohua

AU - Ye, Chunting

AU - Dang, Ying

AU - Manjunath, N.

AU - Wu, Haoquan

AU - Shankar, Premlata

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Multiplexed miRNA-based shRNAs (shRNA-miRs) could have wide potential to simultaneously suppress multiple genes. Here, we describe a simple strategy to express a large number of shRNA-miRs using minimal flanking sequences from multiple endogenous miRNAs. We found that a sequence of 30 nucleotides flanking the miRNA duplex was sufficient for efficient processing of shRNA-miRs. We inserted multiple shRNAs in tandem, each containing minimal flanking sequence from a different miRNA. Deep sequencing of transfected cells showed accurate processing of individual shRNA-miRs and that their expression did not decrease with the distance from the promoter. Moreover, each shRNA was as functionally competent as its singly expressed counterpart. We used this system to express one shRNA-miR targeting CCR5 and six shRNA-miRs targeting the HIV-1 genome. The lentiviral construct was pseudotyped with HIV-1 envelope to allow transduction of both resting and activated primary CD4 T cells. Unlike one shRNA-miR, the seven shRNA-miR transduced T cells nearly abrogated HIV-1 infection in vitro. Additionally, when PBMCs from HIV-1 seropositive individuals were transduced and transplanted into NOD/SCID/IL-2R γc -/- mice (Hu-PBL model) efficient suppression of endogenous HIV-1 replication with restoration of CD4 T cell counts was observed. Thus, our multiplexed shRNA appears to provide a promising gene therapeutic approach for HIV-1 infection.

AB - Multiplexed miRNA-based shRNAs (shRNA-miRs) could have wide potential to simultaneously suppress multiple genes. Here, we describe a simple strategy to express a large number of shRNA-miRs using minimal flanking sequences from multiple endogenous miRNAs. We found that a sequence of 30 nucleotides flanking the miRNA duplex was sufficient for efficient processing of shRNA-miRs. We inserted multiple shRNAs in tandem, each containing minimal flanking sequence from a different miRNA. Deep sequencing of transfected cells showed accurate processing of individual shRNA-miRs and that their expression did not decrease with the distance from the promoter. Moreover, each shRNA was as functionally competent as its singly expressed counterpart. We used this system to express one shRNA-miR targeting CCR5 and six shRNA-miRs targeting the HIV-1 genome. The lentiviral construct was pseudotyped with HIV-1 envelope to allow transduction of both resting and activated primary CD4 T cells. Unlike one shRNA-miR, the seven shRNA-miR transduced T cells nearly abrogated HIV-1 infection in vitro. Additionally, when PBMCs from HIV-1 seropositive individuals were transduced and transplanted into NOD/SCID/IL-2R γc -/- mice (Hu-PBL model) efficient suppression of endogenous HIV-1 replication with restoration of CD4 T cell counts was observed. Thus, our multiplexed shRNA appears to provide a promising gene therapeutic approach for HIV-1 infection.

UR - http://www.scopus.com/inward/record.url?scp=84922224353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922224353&partnerID=8YFLogxK

U2 - 10.1038/mt.2014.205

DO - 10.1038/mt.2014.205

M3 - Article

C2 - 25358251

AN - SCOPUS:84922224353

VL - 23

SP - 310

EP - 320

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 2

ER -